NYSE
RCUS
Arcus Biosciences, Inc.
- Health Care
- Listed 2018
- 1 day
- +2.3%
- 1 month
- −6.3%
- 1 year
- +199%
$28.33 · Mkt cap $3.56B
At the 6 Aug 2026 close
NYSE
Arcus Biosciences, Inc.
$28.33 · Mkt cap $3.56B
At the 6 Aug 2026 close
Arcus Biosciences, Inc. trades under the ticker RCUS on NYSE, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2018. Its market capitalisation is $3.56B. The last closing price was $28.33, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +199%, and −6.3% over the past month. Returns are price returns and exclude dividends.
This page exists because RCUS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.